Stay updated on GLPG2222 in Ivacaftor-treated CF: Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page.

Latest updates to the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4. This reflects a minor deployment update rather than any change to study data.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, signaling a minor site update. This change represents an internal revision label and does not modify the study details shown on the page.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a newer revision of the page content. This change does not modify the study data or user-facing information.SummaryDifference0.0%

- Check49 days agoChange DetectedThe study page now indicates that recruitment is closed. Additionally, new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added, and there are minor heading/version label updates indicating formatting changes.SummaryDifference0.4%

- Check56 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page version rather than a modification to the study content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe sponsor field now lists Lakefront Biotherapeutics NV instead of Galapagos NV. This reflects a transition of sponsorship for the study.SummaryDifference0.2%

Stay in the know with updates to GLPG2222 in Ivacaftor-treated CF: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page.